Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study
Tài liệu tham khảo
Jeong, 2013, Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy, Radiation Oncol J, 31, 206, 10.3857/roj.2013.31.4.206
Schwartz, 1994, Synchronous and metachronous head and neck carcinomas, Cancer, 74, 1933, 10.1002/1097-0142(19941001)74:7<1933::AID-CNCR2820740718>3.0.CO;2-X
Hoebers F, Heemsbergen W, Moor S, Lopez M, Klop M, Tesselaar M, et al. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity. Int J Radiat Oncol Biol Phys. 2011;81(3):e111-8.
Wong, 2006, Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?, J Clin Oncol, 24, 2653, 10.1200/JCO.2005.05.3850
Vargo, 2012, Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck, Head Neck, 34, 1153, 10.1002/hed.21889
Chen, 2014, Functional and quality-of-life outcomes after reirradiation for head and neck cancer, Laryngoscope, 124, 1807, 10.1002/lary.24505
Kim, 2017, Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence, Radiat Oncol J, 35, 1, 10.3857/roj.2017.00122
Strojan, 2015, Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate, Head Neck, 37, 134, 10.1002/hed.23542
Cacicedo, 2014, The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach, Cancer Treat Rev, 40, 178, 10.1016/j.ctrv.2013.08.002
Eisbruch, 1999, RE-Irradiation of head and neck tumors, Cancer, 13, 825
Lee, 2020, Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: meta-analysis and systematic review, Head Neck, 42, 2473, 10.1002/hed.26264
Langendijk, 2006, A phase II study of primary reirradiation in squamous cell carcinoma of head and neck, Radiother Oncol, 78, 306, 10.1016/j.radonc.2006.02.003
Spencer, 2008, Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck, Head Neck, 30, 281, 10.1002/hed.20697
DAHANCA. Retningslinjer for strålebehandling i DAHANCA-2013. www.dahanca.dk; 2013. Report No.: 4.
Skjøtskift, 2018, Dose painting for re-irradiation of head and neck cancer, Acta Oncol, 57, 1693, 10.1080/0284186X.2018.1512753
Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8
NIH NCI, Division of Cancer Treatment and Diagnosis (DCTD) Common Terminology Criteria for Adverse Events (CTCAE) – EORTC. 2009.
Bjordal, 2000, A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group, Eur J Cancer, 36, 1796, 10.1016/S0959-8049(00)00186-6
Osoba, 1997, Current applications of health-related quality-of-life assessment in oncology, Support Care Cancer, 5, 100, 10.1007/BF01262565
Fayers P, Aaronsen N, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. The EORTC QLQ-C30 Scoring Manual (3rd Edition). 2001.
Woods, 2022, A Prospective Phase II study of automated non-coplanar VMAT for recurrent head and neck cancer: initial report of feasibility, safety, and patient-reported outcomes, Cancers (Basel), 14, 939, 10.3390/cancers14040939
Vargo, 2014, Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer, Laryngoscope, 124, 1579, 10.1002/lary.24441
Gogineni, 2019, Quality of life outcomes following organ-sparing SBRT in previously irradiated recurrent head and neck cancer, Front Oncol, 9, 10.3389/fonc.2019.00836
Duprez, 2014, High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity, Radiother Oncol, 111, 388, 10.1016/j.radonc.2014.04.018
McDonald, 2012, Risk of carotid blowout after reirradiation of the head and neck: a systematic review, Int J Radiat Oncol Biol Phys, 82, 1083, 10.1016/j.ijrobp.2010.08.029
Xiao, 2015, Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy, PLoS One, 10, e0125351, 10.1371/journal.pone.0125351
Burtness, 2019, Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study, Lancet, 394, 1915, 10.1016/S0140-6736(19)32591-7
Svajdova, 2021, Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: critical review, Head Neck, 43, 354, 10.1002/hed.26485
Ho, 2018, Reirradiation of head and neck cancer using modern highly conformal techniques, Head Neck, 40, 2078, 10.1002/hed.25180
Roesch, 2023, Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis, Radiother Oncol, 181, 109380, 10.1016/j.radonc.2022.10.007
Ward, 2018, Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT Era: a multi-institution cohort study by the MIRI collaborative, Int J Radiat Oncol Biol Phys, 100, 586, 10.1016/j.ijrobp.2017.06.012
Rühle, 2020, The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer, Radiat Oncol, 15, 10.1186/s13014-020-01531-5
Caudell, 2018, Volume, dose, and fractionation considerations for IMRT-based reirradiation in head and neck cancer: a multi-institution analysis, Int J Radiat Oncol Biol Phys, 100, 606, 10.1016/j.ijrobp.2017.11.036
Altay-Langguth, 2021, Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study, Clin Transl Radiat Oncol, 28, 71
Gordon, 2021, Proton re-irradiation of unresectable recurrent head and neck cancers, Rep Pract Oncol Radiother, 26, 203, 10.5603/RPOR.a2021.0029